Literature DB >> 27860076

Incoming human papillomavirus 16 genome is lost in PML protein-deficient HaCaT keratinocytes.

Malgorzata Bienkowska-Haba1, Wioleta Luszczek1, Timothy R Keiffer1, Lucile G M Guion1, Stephen DiGiuseppe1, Rona S Scott1, Martin Sapp1.   

Abstract

Human papillomaviruses (HPVs) target promyelocytic leukemia (PML) nuclear bodies (NBs) during infectious entry and PML protein is important for efficient transcription of incoming viral genome. However, the transcriptional down regulation was shown to be promoter-independent in that heterologous promoters delivered by papillomavirus particles were also affected. To further investigate the role of PML protein in HPV entry, we used small hairpin RNA to knockdown PML protein in HaCaT keratinocytes. Confirming previous findings, PML knockdown in HaCaT cells reduced HPV16 transcript levels significantly following infectious entry without impairing binding and trafficking. However, when we quantified steady-state levels of pseudogenomes in interphase cells, we found strongly reduced genome levels compared with parental HaCaT cells. Because nuclear delivery was comparable in both cell lines, we conclude that viral pseudogenome must be removed after successful nuclear delivery. Transcriptome analysis by gene array revealed that PML knockdown in clonal HaCaT cells was associated with a constitutive interferon response. Abrogation of JAK1/2 signaling prevented genome loss, however, did not restore viral transcription. In contrast, knockdown of PML protein in HeLa cells did not affect HPV genome delivery and transcription. HeLa cells are transformed by HPV18 oncogenes E6 and E7, which have been shown to interfere with the JAK/Stat signaling pathway. Our data imply that PML NBs protect incoming HPV genomes. Furthermore, they provide evidence that PML NBs are key regulators of the innate immune response in keratinocytes. IMPORTANCE: Promyelocytic leukemia nuclear bodies (PML NBs) are important for antiviral defense. Many DNA viruses target these subnuclear structures and reorganize them. Reorganization of PML NBs by viral proteins is important for establishment of infection. In contrast, HPVs require the presence of PML protein for efficient transcription of incoming viral genome. Our finding that PML protein prevents the loss of HPV genome following infection implies that the host cell may be able to recognize chromatinized HPV genome or the associated capsid proteins. A constitutively active interferon response in absence of PML protein suggests that PML NBs are key regulators of the innate immune response in keratinocytes.
© 2016 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27860076      PMCID: PMC5382090          DOI: 10.1111/cmi.12708

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  97 in total

1.  Cleavage of the papillomavirus minor capsid protein, L2, at a furin consensus site is necessary for infection.

Authors:  Rebecca M Richards; Douglas R Lowy; John T Schiller; Patricia M Day
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

2.  Promyelocytic leukemia bodies tether to early endosomes during mitosis.

Authors:  Vuk Palibrk; Emma Lång; Anna Lång; Kay Oliver Schink; Alexander D Rowe; Stig Ove Bøe
Journal:  Cell Cycle       Date:  2014-03-26       Impact factor: 4.534

3.  An L2 SUMO interacting motif is important for PML localization and infection of human papillomavirus type 16.

Authors:  Timo Bund; Gilles A Spoden; Kaloian Koynov; Nadja Hellmann; Fatima Boukhallouk; Philipp Arnold; Dariush Hinderberger; Luise Florin
Journal:  Cell Microbiol       Date:  2014-03-12       Impact factor: 3.715

4.  PML positively regulates interferon gamma signaling.

Authors:  Jamila El Bougrini; Laurent Dianoux; Mounira K Chelbi-Alix
Journal:  Biochimie       Date:  2010-11-27       Impact factor: 4.079

5.  High-risk human papillomaviruses repress constitutive kappa interferon transcription via E6 to prevent pathogen recognition receptor and antiviral-gene expression.

Authors:  Jeanette Reiser; José Hurst; Maike Voges; Peter Krauss; Peter Münch; Thomas Iftner; Frank Stubenrauch
Journal:  J Virol       Date:  2011-08-17       Impact factor: 5.103

6.  Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression.

Authors:  Patricia M Day; Carl C Baker; Douglas R Lowy; John T Schiller
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-21       Impact factor: 11.205

7.  The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses.

Authors:  Vijay A K Rathinam; Zhaozhao Jiang; Stephen N Waggoner; Shruti Sharma; Leah E Cole; Lisa Waggoner; Sivapriya Kailasan Vanaja; Brian G Monks; Sandhya Ganesan; Eicke Latz; Veit Hornung; Stefanie N Vogel; Eva Szomolanyi-Tsuda; Katherine A Fitzgerald
Journal:  Nat Immunol       Date:  2010-03-28       Impact factor: 25.606

8.  Analysis of type-restricted and cross-reactive epitopes on virus-like particles of human papillomavirus type 33 and in infected tissues using monoclonal antibodies to the major capsid protein.

Authors:  M Sapp; U Kraus; C Volpers; P J Snijders; J M Walboomers; R E Streeck
Journal:  J Gen Virol       Date:  1994-12       Impact factor: 3.891

9.  Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan.

Authors:  Jeffrey N Roberts; Christopher B Buck; Cynthia D Thompson; Rhonda Kines; Marcelino Bernardo; Peter L Choyke; Douglas R Lowy; John T Schiller
Journal:  Nat Med       Date:  2007-07-01       Impact factor: 53.440

10.  Vesicular trafficking of incoming human papillomavirus 16 to the Golgi apparatus and endoplasmic reticulum requires γ-secretase activity.

Authors:  Wei Zhang; Teymur Kazakov; Andreea Popa; Daniel DiMaio
Journal:  mBio       Date:  2014-09-16       Impact factor: 7.867

View more
  13 in total

Review 1.  Opportunities and challenges for human papillomavirus vaccination in cancer.

Authors:  Richard B S Roden; Peter L Stern
Journal:  Nat Rev Cancer       Date:  2018-03-02       Impact factor: 60.716

2.  A new cell culture model to genetically dissect the complete human papillomavirus life cycle.

Authors:  Malgorzata Bienkowska-Haba; Wioleta Luszczek; Julia E Myers; Timothy R Keiffer; Stephen DiGiuseppe; Paula Polk; Jason M Bodily; Rona S Scott; Martin Sapp
Journal:  PLoS Pathog       Date:  2018-03-01       Impact factor: 6.823

3.  PML nuclear body-residing proteins sequentially associate with HPV genome after infectious nuclear delivery.

Authors:  Lucile Guion; Malgorzata Bienkowska-Haba; Stephen DiGiuseppe; Luise Florin; Martin Sapp
Journal:  PLoS Pathog       Date:  2019-02-25       Impact factor: 6.823

Review 4.  Replication Compartments of DNA Viruses in the Nucleus: Location, Location, Location.

Authors:  Matthew Charman; Matthew D Weitzman
Journal:  Viruses       Date:  2020-01-29       Impact factor: 5.048

Review 5.  The Role of ND10 Nuclear Bodies in Herpesvirus Infection: A Frenemy for the Virus?

Authors:  Behdokht Jan Fada; Eleazar Reward; Haidong Gu
Journal:  Viruses       Date:  2021-02-03       Impact factor: 5.048

6.  Vesicular trafficking permits evasion of cGAS/STING surveillance during initial human papillomavirus infection.

Authors:  Brittany L Uhlorn; Robert Jackson; Shuaizhi Li; Shauna M Bratton; Koenraad Van Doorslaer; Samuel K Campos
Journal:  PLoS Pathog       Date:  2020-11-30       Impact factor: 6.823

Review 7.  HPV16 Entry into Epithelial Cells: Running a Gauntlet.

Authors:  Snježana Mikuličić; Johannes Strunk; Luise Florin
Journal:  Viruses       Date:  2021-12-08       Impact factor: 5.048

8.  Heterotetrameric annexin A2/S100A10 (A2t) is essential for oncogenic human papillomavirus trafficking and capsid disassembly, and protects virions from lysosomal degradation.

Authors:  Julia R Taylor; Daniel J Fernandez; Shantaé M Thornton; Joseph G Skeate; Kim P Lühen; Diane M Da Silva; Ralf Langen; W Martin Kast
Journal:  Sci Rep       Date:  2018-08-03       Impact factor: 4.379

Review 9.  Papillomaviruses and Endocytic Trafficking.

Authors:  Abida Siddiqa; Justyna Broniarczyk; Lawrence Banks
Journal:  Int J Mol Sci       Date:  2018-09-04       Impact factor: 5.923

Review 10.  The Role of Promyelocytic Leukemia Nuclear Bodies During HPV Infection.

Authors:  Lucile G Guion; Martin Sapp
Journal:  Front Cell Infect Microbiol       Date:  2020-02-19       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.